MEDINA participates in the NOVA-VRE project to develop new therapies to combat antibiotic-resistant bacteria

by MEDINA

MEDINA participates in the NOVA-VRE project to develop new therapies to combat antibiotic-resistant bacteria.

Read more

El papel esencial de los estudios preclínicos no regulatorios en el descubrimiento de fármacos

by MEDINA

El camino que recorre un compuesto bioactivo antes de convertirse en un medicamento seguro y eficaz es largo, complejo y altamente regulado. Antes de avanzar a las fases clínicas, todo candidato debe...

Read more

Fundacion MEDINA Strengthens Its Commitment to Transparency in Animal Research

by MEDINA

Fundacion MEDINA reaffirms its commitment to transparency in the use of animals for biomedical research, a principle it embraced in 2022 when it joined the Transparency Agreement on Animal Research, p...

Read more

Fundación MEDINA presenta en Boston m3DinAI, una Nueva Plataforma de Cribado de Fármacos Antitumorales

by MEDINA

Fundación MEDINA presenta en Boston m3DinAI, una Nueva Plataforma de Cribado de Fármacos Antitumorales

Read more

The PROSPLIGN project: Fundacion MEDINA participates as a partner in the launch of a €3.4 Million Project on Lignin Bioprospecting

by MEDINA

The key project objective is to apply state-of-the-art methodologies to prospect the bioactivity potential of lignin – a natural, abundant and sustainable biopolymer component of lignocellulosic bio...

Read more

Fundación MEDINA, DNDi and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease

by MEDINA

Fundación MEDINA, the Drugs for Neglected Diseases initiative (DNDi) and Institut Pasteur Korea have been awarded a grant of EUR 995,000 from “la Caixa” Health Research 2020 program to identify n...

Read more

Fundación MEDINA: Programa H2020 TOPCAPI para la generación de factorías microbianas

by MEDINA

​Fundación MEDINA participará en el proyecto europeo del programa H2020 TOPCAPI, para la generación de factorías microbianas donde producir fármacos avanzados. Así, MEDINA participará en desa...

Read more

Fundación MEDINA presents during the symposium FiAAD the results of a research focused on the identification of new antibiotics and antiinfective treatments

by MEDINA

The symposium is organized jointly by the Medicinal Chemistry Section of the Swedish Pharmaceutical Society and ENABLE, one of the projects in the Innovative Medicines Initiative ND4BB in which MEDINA...

Read more

European BLUEandGREEN Project was launched

by MEDINA

BLUEandGREEN will be a complementary transdisciplinary effort of the five partners that will contribute on raising CIIMAR's scientific and technological standards in biorefineries approach based on ma...

Read more

€85million European programme targets novel antibiotics

by MEDINA
  • 13 years ago

MEDINA will develop its first novel antibiotic in a new European consortium aimed at bringing innovative solutions to fight bacterial infectious diseases. Over 30 European universities and c...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Collagen, the human body’s most abunda...

by Centre for Genomic Regulation

The finding is the first direct observation of how the most abundant p...

Photos Stream